Poverty amplifies Africa’s snakebite problem
“We have seen an influx of patients in several MSF hospitals following introduction of free-of-charge antivenoms,” Potet says.
African governments should recognise snakebite treatment as an essential part of universal health coverage,” says Potet.Globally, not much is being done to deal with snakebite in Africa either, Chippaux agrees.
Germany, which used to make antivenom for Africa, stopped in the 1990s and France stopped in 2010.
Soobrayan died on 29 September after being bitten by a black mamba, whose venom he was trying to extract.
There are manufacturers in Algeria, Egypt, South Africa and Tunisia, but they are not looking to sell outside their own countries.